Cointime

Immune Design

company

About

Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.

  • 11 - 50

Highlights

Total Funding Amount
$99M
Funding Rounds
3
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$49M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$99M
Immune Design has raised a total of $99M in funding over 2 rounds. Their latest funding was raised on Oct 30, 2013 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 30, 2013 Series C $49M 1 — — Detail
Jul 26, 2010 Series B $32M 1 — — Detail
Jul 7, 2008 Series A $18M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Immune Design is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series C
Cointime
เนื้อหา
บริษัท